140 related articles for article (PubMed ID: 3180395)
1. New pluronic-free perfluorocarbon cardioplegia improves myocardial oxygenation.
Johnson DL; Greene PS; Gott VL; Gardner TJ
Circulation; 1988 Nov; 78(5 Pt 2):III153-7. PubMed ID: 3180395
[TBL] [Abstract][Full Text] [Related]
2. Superiority of perfluorocarbon cardioplegia over blood or crystalloid cardioplegia.
Kanter KR; Jaffin JH; Ehrlichman RJ; Flaherty JT; Gott VL; Gardner TJ
Circulation; 1981 Aug; 64(2 Pt 2):II75-80. PubMed ID: 7249332
[TBL] [Abstract][Full Text] [Related]
3. Ischemic myocardial protection. Comparison of nonoxygenated crystalloid, oxygenated crystalloid, and oxygenated fluorocarbon cardioplegic solutions.
Tabayashi K; McKeown PP; Miyamoto M; Luedtke AE; Thomas R; Allen MD; Misbach GA; Ivey TD
J Thorac Cardiovasc Surg; 1988 Feb; 95(2):239-46. PubMed ID: 3339891
[TBL] [Abstract][Full Text] [Related]
4. Improved myocardial protection with perfluorocarbon cardioplegia.
Gardner TJ; Flaherty JT; Kanter KR; Magovern GJ
Prog Clin Biol Res; 1983; 122():405-17. PubMed ID: 6878379
[TBL] [Abstract][Full Text] [Related]
5. Failure of blood cardioplegia to protect myocardium at lower temperatures.
Magovern GJ; Flaherty JT; Gott VL; Bulkley BH; Gardner TJ
Circulation; 1982 Aug; 66(2 Pt 2):I60-7. PubMed ID: 6805979
[TBL] [Abstract][Full Text] [Related]
6. Protein kinase C isoform-dependent myocardial protection by ischemic preconditioning and potassium cardioplegia.
Lu K; Otani H; Yamamura T; Nakao Y; Hattori R; Ninomiya H; Osako M; Imamura H
J Thorac Cardiovasc Surg; 2001 Jan; 121(1):137-48. PubMed ID: 11135170
[TBL] [Abstract][Full Text] [Related]
7. Enhanced myocardial protection during ischemic arrest. Oxygenation of a crystalloid cardioplegic solution.
Bodenhamer RM; DeBoer LW; Geffin GA; O'Keefe DD; Fallon JT; Aretz TH; Haas GS; Daggett WM
J Thorac Cardiovasc Surg; 1983 May; 85(5):769-80. PubMed ID: 6843158
[TBL] [Abstract][Full Text] [Related]
8. Protection of the hypertrophied pig myocardium. A comparison of crystalloid, blood, and Fluosol-DA cardioplegia during prolonged aortic clamping.
Novick RJ; Stefaniszyn HJ; Michel RP; Burdon FD; Salerno TA
J Thorac Cardiovasc Surg; 1985 Apr; 89(4):547-66. PubMed ID: 3157028
[TBL] [Abstract][Full Text] [Related]
9. The effect of amino acids on the ischemic heart. Improvement of oxygenated crystalloid cardioplegic solution by an enriched branched chain amino acid formulation.
Schwalb H; Izhar U; Yaroslavsky E; Borman JB; Uretzky G
J Thorac Cardiovasc Surg; 1989 Oct; 98(4):551-6. PubMed ID: 2796362
[TBL] [Abstract][Full Text] [Related]
10. Maintenance of the myocardial thiol pool by N-acetylcysteine. An effective means of improving cardioplegic protection.
Menasché P; Grousset C; Gauduel Y; Mouas C; Piwnica A
J Thorac Cardiovasc Surg; 1992 May; 103(5):936-44. PubMed ID: 1569775
[TBL] [Abstract][Full Text] [Related]
11. [Functional and metabolic effects of nicardipine on ischemic rat hearts with multidose potassium cardioplegia].
Tachibana H
Nihon Kyobu Geka Gakkai Zasshi; 1990 Apr; 38(4):630-40. PubMed ID: 2373897
[TBL] [Abstract][Full Text] [Related]
12. Enhancement of crystalloid cardioplegic protection against global normothermic ischemia by superoxide dismutase plus catalase but not diltiazem in the isolated, working rat heart.
Greenfield DT; Greenfield LJ; Hess ML
J Thorac Cardiovasc Surg; 1988 May; 95(5):799-813. PubMed ID: 3361928
[TBL] [Abstract][Full Text] [Related]
13. Studies of controlled reperfusion after ischemia. XXI. Reperfusate composition: superiority of blood cardioplegia over crystalloid cardioplegia in limiting reperfusion damage--importance of endogenous oxygen free radical scavengers in red blood cells.
Julia PL; Buckberg GD; Acar C; Partington MT; Sherman MP
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):303-13. PubMed ID: 1992241
[TBL] [Abstract][Full Text] [Related]
14. Age-related changes in the ability of hypothermia and cardioplegia to protect ischemic rabbit myocardium.
Baker JE; Boerboom LE; Olinger GN
J Thorac Cardiovasc Surg; 1988 Nov; 96(5):717-24. PubMed ID: 3184966
[TBL] [Abstract][Full Text] [Related]
15. Effects of supplementing hypothermic crystalloid cardioplegic solution with catalase, superoxide dismutase, allopurinol, or deferoxamine on functional recovery of globally ischemic and reperfused isolated hearts.
Myers CL; Weiss SJ; Kirsh MM; Shepard BM; Shlafer M
J Thorac Cardiovasc Surg; 1986 Feb; 91(2):281-9. PubMed ID: 3945095
[TBL] [Abstract][Full Text] [Related]
16. Myocardial energetics after thermally graded hyperkalemic crystalloid cardioplegic arrest.
Krukenkamp I; Silverman N; Sorlie D; Pridjian A; Feinberg H; Levitsky S
J Thorac Cardiovasc Surg; 1986 Jul; 92(1):56-62. PubMed ID: 3724227
[TBL] [Abstract][Full Text] [Related]
17. Effect of an oxygen-enriched solution and multiple dosing of antegrade crystalloid cardioplegic solution on myocardial metabolism during coronary artery bypass graft operations.
Downey RS; Weintraub WS; Jones EL; Conn RB; Ash T
J Thorac Cardiovasc Surg; 1992 Oct; 104(4):1148-7. PubMed ID: 1405675
[TBL] [Abstract][Full Text] [Related]
18. The effect of temperature and hematocrit level of oxygenated cardioplegic solutions on myocardial preservation.
Rousou JA; Engelman RM; Breyer RH; Otani H; Lemeshow S; Das DK
J Thorac Cardiovasc Surg; 1988 Apr; 95(4):625-30. PubMed ID: 3352296
[TBL] [Abstract][Full Text] [Related]
19. Protection of the myocardium during global ischemia. Is crystalloid cardioplegia effective in the immature myocardium?
Avkiran M; Hearse DJ
J Thorac Cardiovasc Surg; 1989 Feb; 97(2):220-8. PubMed ID: 2915557
[TBL] [Abstract][Full Text] [Related]
20. Studies of controlled reperfusion after ischemia. XIX. Reperfusate composition: benefits of blood cardioplegia over fluosol DA cardioplegia during regional reperfusion--importance of including blood components in the initial reperfusate.
Acar C; Partington MT; Buckberg GD
J Thorac Cardiovasc Surg; 1991 Feb; 101(2):284-93. PubMed ID: 1992239
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
